Meal timing matters: new drug zongertinib tested with and without food
NCT ID NCT06075277
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study looked at how taking the drug zongertinib with or without food changes the amount that gets into the blood. Sixteen healthy men each took one dose of the drug in two different conditions: after a high-fat meal and on an empty stomach. The results will help doctors decide the best way to take this medicine in future trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CRS Clinical Research Services Berlin GmbH
Berlin, 13627, Germany
Conditions
Explore the condition pages connected to this study.